First New York Securities’s Novo Nordisk NVO Stock Holding History

First New York Securities’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$538K	Buy	+30,000	New	+$544K	1%	11
2016 Q3	–	Sell	-10,000	Closed	-$269K	–	295
2016 Q2	$269K	Sell	10,000 -64,000	-86%	-$1.76M	0.17%	45
2016 Q1	$2.01M	Buy	+74,000	New	+$1.98M	1.38%	13
2015 Q4	–	Sell	-102,000	Closed	-$2.77M	–	193
2015 Q3	$2.77M	Buy	+102,000	New	+$2.89M	1.25%	17
2014 Q4	–	Sell	-10,000	Closed	-$238K	–	476
2014 Q3	$238K	Sell	10,000 -60,000	-86%	-$1.38M	0.17%	109
2014 Q2	$1.62M	Buy	70,000 +15,000	+27%	+$331K	1.67%	10
2014 Q1	$1.25M	Buy	+55,000	New	+$1.17M	0.62%	40
2013 Q4	–	Sell	-11,000	Closed	-$186K	–	348
2013 Q3	$186K	Sell	11,000 -404,000	-97%	-$6.79M	0.07%	180
2013 Q2	$6.43M	Buy	+415,000	New	+$6.91M	2.41%	10

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

First New York Securities's NVO Position: Q4 2016 in Review

First New York Securities opened a new position in Novo Nordisk (NVO) in Q4 2016: 30,000 shares worth $538K. The stake represents 1% of the portfolio and ranks #11 among its holdings. This is a return to the name: First New York Securities previously reported a position in NVO as recently as Q2 2016.

First New York Securities first reported a position in NVO in Q2 2013 and has held it in 9 quarters since. The position peaked at $6.43M in Q2 2013. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

First New York Securities held 30,000 shares of Novo Nordisk worth $538K as of Q4 2016.
Novo Nordisk was a new First New York Securities position in Q4 2016.
Novo Nordisk made up 1% of First New York Securities's portfolio in Q4 2016, its #11 holding.
First New York Securities first reported a position in Novo Nordisk in Q2 2013 and has held it in 9 quarters since.
First New York Securities's Novo Nordisk position peaked at $6.43M in Q2 2013.
483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.